Specific solutions for specific challenges in global industries.

Fórmida-A

A tailor-made zootechnical additive based on bacteriophage technology capable of inhibiting the growth of E. coli strains associated with avian colibacillosis, as well as helping to enhance the effectiveness of antibiotic therapy in specific geographic territories.

FÓRMIDA-A contains 4 specific bacteriophages against Escherichia coli.

Request more info

Composition

Liquid product. Contains bacteriophages isolated from natural sources, without modifications to their genome (non-GMO).

Dosage

1L per 20,000 birds diluted in drinking water during the rearing period with a dosing interval of 2 to 7 days.

Target species

Poultry throughout the breeding period (broilers and rearing flocks).

Safety

All product components are safe for the user and for the final consumer.

Main benefits

More resilient birds: reduces clinical signs of colibacillosis by 42%.
Fewer lesions: reduces the presence of lesions associated with aerosaculitis and pericarditis in birds by 76% when administered alongside conventional treatments against APEC.
Greater protection: reduces the prevalence of colibacillosis by 50% when administered alongside conventional treatments against it.
High efficacy: natural bacteriophages selected for their specific and powerful activity against the most prevalent serovars in Brazilian farms.
No withdrawal period: can be applied up to one day before sending to the processing plant.

“The continuous rise of antibiotic-resistant Escherichia coli infections has had strong negative impacts on the general health and safety of animals within the poultry industry. In this context, FÓRMIDA aims to improve the general health of animals by reducing the infections caused by Escherichia coli, especially antibiotic-resistant E.coli.”

Nicolás Cifuentes

Head of Research Projects & Phages at PhageLab